Alice S. van Velzen

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters et al. · Blood · 2013 · 214 citations · Full text

Inhibitor development and mortality in non‐severe hemophilia A

Corien L. Eckhardt, J.I. Loomans, Alice S. van Velzen et al. · Journal of Thrombosis and Haemostasis · 2015 · 74 citations · Full text

Intensity of factor VIII treatment and the development of inhibitors in non‐severe hemophilia A patients: results of the INSIGHT case–control study

Alice S. van Velzen, Corien L. Eckhardt, Marjolein Peters et al. · Journal of Thrombosis and Haemostasis · 2017 · 36 citations · Full text

Factor Viii Treatment, Hematology, Insight Case–control Study +6

Inhibitors in nonsevere haemophilia A: outcome and eradication strategies

Alice S. van Velzen, Corien L. Eckhardt, Daniel P. Hart et al. · Thrombosis and Haemostasis · 2015 · 35 citations

Desmopressin in moderate hemophilia A patients: a treatment worth considering

J.I. Loomans, Marieke J.H.A. Kruip, Manuel Carção et al. · Haematologica · 2018 · 32 citations · Full text

Inflammation, Clinical Disorders, Factor Viii Levels +14